Multi-omics and experimental analysis unveil theragnostic value and immunological roles of inner membrane mitochondrial protein (IMMT) in breast cancer

被引:0
|
作者
Hung-Yu Lin
Hsing-Ju Wu
Pei-Yi Chu
机构
[1] National Chung Hsing University,Department of Post
[2] Show Chwan Memorial Hospital,Baccalaureate Medicine, College of Medicine
[3] National Changhua University of Education,Research Assistant Center
[4] Fu Jen Catholic University,Department of Biology
[5] Show Chwan Memorial Hospital,School of Medicine, College of Medicine
[6] Chung Chou University of Science and Technology,Department of Pathology
[7] National Health Research Institutes,Department of Health Food
关键词
Breast cancer; Inner membrane mitochondrial protein; Diagnostic biomarker; Prognosis; Precision medicine; Tumor immune microenvironment;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Integrated Multi-Omics Analysis Model to Identify Biomarkers Associated With Prognosis of Breast Cancer
    Fan, Yeye
    Kao, Chunyu
    Yang, Fu
    Wang, Fei
    Yin, Gengshen
    Wang, Yongjiu
    He, Yong
    Ji, Jiadong
    Liu, Liyuan
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [22] Prognostic value analysis of cholesterol and cholesterol homeostasis related genes in breast cancer by Mendelian randomization and multi-omics machine learning
    Wu, Haodong
    Wu, Zhixuan
    Ye, Daijiao
    Li, Hongfeng
    Dai, Yinwei
    Wang, Ziqiong
    Bao, Jingxia
    Xu, Yiying
    He, Xiaofei
    Wang, Xiaowu
    Dai, Xuanxuan
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [23] Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes
    Brian D. Lehmann
    Antonio Colaprico
    Tiago C. Silva
    Jianjiao Chen
    Hanbing An
    Yuguang Ban
    Hanchen Huang
    Lily Wang
    Jamaal L. James
    Justin M. Balko
    Paula I. Gonzalez-Ericsson
    Melinda E. Sanders
    Bing Zhang
    Jennifer A. Pietenpol
    X. Steven Chen
    Nature Communications, 12
  • [24] Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes
    Lehmann, Brian D.
    Colaprico, Antonio
    Silva, Tiago C.
    Chen, Jianjiao
    An, Hanbing
    Ban, Yuguang
    Huang, Hanchen
    Wang, Lily
    James, Jamaal L.
    Balko, Justin M.
    Gonzalez-Ericsson, Paula I.
    Sanders, Melinda E.
    Zhang, Bing
    Pietenpol, Jennifer A.
    Chen, X. Steven
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [25] Multi-omics analysis revealed the mitochondrial-targeted drug combination to suppress the development of lung cancer
    Li, Chaoqun
    Zhang, Yanfei
    Xia, Qing
    Hao, Bingjie
    Hong, Yifan
    Yue, Liduo
    Zheng, Tiansheng
    Li, Ming
    Fan, Lihong
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (19) : 17159 - 17174
  • [26] Multi-omics analysis revealed the mitochondrial-targeted drug combination to suppress the development of lung cancer
    Chaoqun Li
    Yanfei Zhang
    Qing Xia
    Bingjie Hao
    Yifan Hong
    Liduo Yue
    Tiansheng Zheng
    Ming Li
    Lihong Fan
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 17159 - 17174
  • [27] Pan-cancer multi-omics analysis and orthogonal experimental assessment of epigenetic driver genes
    Halaburkova, Andrea
    Cahais, Vincent
    Novoloaca, Alexei
    Araujo, Mariana Gomes da Silva
    Khoueiry, Rita
    Ghantous, Akram
    Herceg, Zdenko
    GENOME RESEARCH, 2020, 30 (10) : 1517 - 1532
  • [28] The role of UPK1B in gastric cancer: multi-omics analysis and experimental validation
    Haixing Zhu
    Wen Jiang
    Qian Zhang
    Changjun Yu
    Discover Oncology, 16 (1)
  • [29] Multi-omics analyses reveal ClpP activators disrupt essential mitochondrial pathways in triple-negative breast cancer
    Fennell, Emily M. J.
    Aponte-Collazo, Lucas J.
    Pathmasiri, Wimal
    Rushing, Blake R.
    Barker, Natalie K.
    Partridge, Megan C.
    Li, Yuan-Yuan
    White, Cody A.
    Greer, Yoshimi E.
    Herring, Laura E.
    Lipkowitz, Stanley
    Sumner, Susan C. J.
    Iwanowicz, Edwin J.
    Graves, Lee M.
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [30] Multi-omics analyses unravel DNA damage repair-related clusters in breast cancer with experimental validation
    Liu, Peng
    Deng, Xinpei
    Zhou, Huamao
    Xie, Jindong
    Kong, Yanan
    Zou, Yutian
    Yang, Anli
    Li, Xing
    FRONTIERS IN IMMUNOLOGY, 2023, 14